Literature DB >> 18216050

Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis.

Q Ye1, Y Dalavanga, N Poulakis, S U Sixt, J Guzman, U Costabel.   

Abstract

Haem oxygenase (HO)-1 is an oxidative stress responsive protein that may be involved in the pathogenesis of interstitial lung disease. HO-1 expression in alveolar macrophages from bronchoalveolar lavage was investigated in 24 patients with idiopathic pulmonary fibrosis (IPF), 16 with sarcoidosis, 14 with hypersensitivity pneumonitis (HP) and 13 controls. Using immunocytochemistry, HO-1 expression in macrophages was scored semiquantitatively from 0-3 according to increasing intensity. The mean score of 100 macrophages was calculated. Macrophages were cultured and levels of interleukin (IL)-12 and IL-18 in the culture supernatants were measured by ELISA. The mean score of HO-1 was significantly lower in IPF (67) than in sarcoidosis (105), HP (106) or controls (106). There was no significant difference between sarcoidosis, HP and controls. The score of HO-1 correlated positively with the lymphocyte percentage in sarcoidosis and HP. Positive correlations were found between the score of HO-1 and the release of IL-12 and IL-18 by macrophages in IPF. The expression of haem oxygenase-1, a critical defender against oxidative stress, is decreased in macrophages of idiopathic pulmonary fibrosis patients compared with those with granulomatous lung disorders. This supports the hypothesis of an oxidant-antioxidant imbalance in the pathogenesis of idiopathic pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216050     DOI: 10.1183/09031936.00125407

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

Review 1.  Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.

Authors:  Paolo Cameli; Alfonso Carleo; Laura Bergantini; Claudia Landi; Antje Prasse; Elena Bargagli
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

Review 2.  Mitochondrial Dysfunction in Pulmonary Fibrosis.

Authors:  Sunad Rangarajan; Karen Bernard; Victor J Thannickal
Journal:  Ann Am Thorac Soc       Date:  2017-11

3.  Proteasomes in human bronchoalveolar lavage fluid after burn and inhalation injury.

Authors:  Joslyn M Albright; Jacqueline Romero; Vikas Saini; Stephan U Sixt; Melanie D Bird; Elizabeth J Kovacs; Richard L Gamelli; Jürgen Peters; Matthias Majetschak
Journal:  J Burn Care Res       Date:  2009 Nov-Dec       Impact factor: 1.845

4.  Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway.

Authors:  Afshin Ebrahimpour; Min Wang; Li Li; Anil G Jegga; Mark D Bonnen; N Tony Eissa; Ganesh Raghu; Soma Jyothula; Farrah Kheradmand; Nicola A Hanania; Ivan O Rosas; Yohannes T Ghebre
Journal:  J Inflamm (Lond)       Date:  2021-05-19       Impact factor: 4.981

5.  Molecular and cellular mechanisms of pulmonary fibrosis.

Authors:  Nevins W Todd; Irina G Luzina; Sergei P Atamas
Journal:  Fibrogenesis Tissue Repair       Date:  2012-07-23

6.  Antioxidant components of naturally-occurring oils exhibit marked anti-inflammatory activity in epithelial cells of the human upper respiratory system.

Authors:  Meixia Gao; Anju Singh; Kristin Macri; Curt Reynolds; Vandana Singhal; Shyam Biswal; Ernst W Spannhake
Journal:  Respir Res       Date:  2011-07-13

7.  Distinct Profiles of CD163-Positive Macrophages in Idiopathic Interstitial Pneumonias.

Authors:  Masahiro Yamashita; Ryoko Saito; Shinji Yasuhira; Yuh Fukuda; Hironobu Sasamo; Tamotsu Sugai; Kohei Yamauchi; Makoto Maemondo
Journal:  J Immunol Res       Date:  2018-02-04       Impact factor: 4.818

Review 8.  Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?

Authors:  Jan Frohlich; Manlio Vinciguerra
Journal:  Geroscience       Date:  2020-10-06       Impact factor: 7.713

9.  Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.

Authors:  Yohannes T Ghebremariam; John P Cooke; William Gerhart; Carol Griego; Jeremy B Brower; Melanie Doyle-Eisele; Benjamin C Moeller; Qingtao Zhou; Lawrence Ho; Joao de Andrade; Ganesh Raghu; Leif Peterson; Andreana Rivera; Glenn D Rosen
Journal:  J Transl Med       Date:  2015-08-01       Impact factor: 5.531

10.  The therapeutic effect of zerumbone on chronic gastritis via antioxidant mechanisms.

Authors:  Liqing Li; Liang Kong; Hongquan Song
Journal:  Exp Ther Med       Date:  2017-07-17       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.